Cancer immunotherapy: predict outcomes better with combination biomarkers

  • Shanghai China
  • Start: Oct 23 2019 19:00
  • Finish: Oct 23 2019 22:00
  • Time zone: Asia/Shanghai
Immunotherapies are amazing drugs against cancer. However, they still fail for too many patients. In this series of lectures, I present IMPRES and TIDE, two of the best predictors of cancer immunotherapy outcomes.
I also show an easy way to combine them and improve their predictions, using a combination biomarker. Finally, I make suggestions of practical ways to contribute to research on this topic.
Speaker: Mostapha Benhenda, bioinformatician at Melwy.com
You will receive the link to the lectures by registering to this event.